Exact Sciences investor relations material

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States. The company operates through its three business segments: Colorectal Cancer Screening, Breast Cancer Detection, and ColoPath Products. It offers Cologuard, a diagnostic colon test for preventing colorectal cancer;Virtual Colonoscopy, a colorectal cancer screening test that uses 5-10 minutes of transmission of images of the digestive tract to provide virtual visualization of intestines; Cologuard GI, which offers Cologuard to patients at a subsidized price; and Fecal DNA Test that is designed to screen patients at high risk for hereditary nonpolyposis colorectal cancers (Lynch syndrome) or people who are not candidates for Virtual Colonoscopy. Exact Sciences Corporation is based in Madison, Wisconsin.